A61K36/52

Compositions and Methods for Treating and Removing Seborrheic Keratoses
20220133828 · 2022-05-05 ·

A method of diminishing the appearance of or effecting the removal or disappearance of seborrheic keratoses by the application of compositions containing a) one or more, preferably a combination of, dietary antioxidants and/or antioxidant sources, b) one or more hydrating agents and c) one or more keratolytic agents.

Compositions and Methods for Treating and Removing Seborrheic Keratoses
20220133828 · 2022-05-05 ·

A method of diminishing the appearance of or effecting the removal or disappearance of seborrheic keratoses by the application of compositions containing a) one or more, preferably a combination of, dietary antioxidants and/or antioxidant sources, b) one or more hydrating agents and c) one or more keratolytic agents.

LIDAR based 3-D imaging with far-field illumination overlap

Methods and systems for performing 3-D LIDAR measurements of objects simultaneously illuminated by two or more beams of light in the far field are described herein. A 3-D LIDAR based measurement device simultaneously emits at least two beams of light into a three dimensional environment from different locations. A portion of the three dimensional environment is simultaneously illuminated by the two or more light beams at a distance of at least five meters from the LIDAR device. However, the two or more light beams do not overlap at a distance less than five meters from the LIDAR device. The beams of light are slightly divergent, having highest intensity at the device and steadily lower intensity further away. By overlapping illumination beams in the far field, but not near the LIDAR device, overall intensity is maintained at moderate levels throughout the field of view of the LIDAR device.

LIDAR based 3-D imaging with far-field illumination overlap

Methods and systems for performing 3-D LIDAR measurements of objects simultaneously illuminated by two or more beams of light in the far field are described herein. A 3-D LIDAR based measurement device simultaneously emits at least two beams of light into a three dimensional environment from different locations. A portion of the three dimensional environment is simultaneously illuminated by the two or more light beams at a distance of at least five meters from the LIDAR device. However, the two or more light beams do not overlap at a distance less than five meters from the LIDAR device. The beams of light are slightly divergent, having highest intensity at the device and steadily lower intensity further away. By overlapping illumination beams in the far field, but not near the LIDAR device, overall intensity is maintained at moderate levels throughout the field of view of the LIDAR device.

METHODS FOR MAKING MIXED ALLERGEN COMPOSITIONS

Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.

METHODS FOR MAKING MIXED ALLERGEN COMPOSITIONS

Methods of making mixed allergen compositions, e.g., substantially aerobic organism free mixed allergen compositions, and the resulting allergen composition, are provided.

METHOD FOR THE TREATMENT OF DEPRESSION

A method for treating depression in a human subject, which comprises administering for a first time period a fasting mimicking diet (FMD) component providing less than 50% of the normal calorie intake of the subject with both protein restriction and sugar restriction; and administering for a second time period a re-feeding diet component that provides 60-100% of the normal calorie intake of the subject; the fasting mimicking diet component and the re-feeding diet component are administered for multiple cycles, and the subject undergoes a psychotherapeutic treatment for the whole duration of the multiple cycles.

METHOD FOR THE TREATMENT OF DEPRESSION

A method for treating depression in a human subject, which comprises administering for a first time period a fasting mimicking diet (FMD) component providing less than 50% of the normal calorie intake of the subject with both protein restriction and sugar restriction; and administering for a second time period a re-feeding diet component that provides 60-100% of the normal calorie intake of the subject; the fasting mimicking diet component and the re-feeding diet component are administered for multiple cycles, and the subject undergoes a psychotherapeutic treatment for the whole duration of the multiple cycles.

Oral compositions and methods of use

Compositions that include: from 5 wt-% to 30 wt-% of one or more plant based oils based on the total weight of the composition; from 70 wt-% to 95 wt-% of an aqueous phase based on the total weight of the composition; from 0.1 wt-% to 5 wt-% of one or more surfactants based on the total weight of the composition; and from 0.05 wt-% to 3 wt-% of a viscosity modifier, wherein the composition has a pH from 4.5 to 9.5, the composition is an oil in water (o/w) emulsion, and the composition is edible. Methods of utilizing disclosed compositions are also included.

Oral compositions and methods of use

Compositions that include: from 5 wt-% to 30 wt-% of one or more plant based oils based on the total weight of the composition; from 70 wt-% to 95 wt-% of an aqueous phase based on the total weight of the composition; from 0.1 wt-% to 5 wt-% of one or more surfactants based on the total weight of the composition; and from 0.05 wt-% to 3 wt-% of a viscosity modifier, wherein the composition has a pH from 4.5 to 9.5, the composition is an oil in water (o/w) emulsion, and the composition is edible. Methods of utilizing disclosed compositions are also included.